Abstract: Systems and methods for controlling egg quality are provided. An example method can include: moving a plurality of cartons packed with eggs by a conveyor belt; measuring a weight of each carton to decide whether the weight of each carton is within a carton weight tolerance; detecting a moisture level inside the carton to decide whether the moisture level of the carton is within a moisture level tolerance; determining whether a shell of the egg is intact and a volume of egg yolk and white is within a volume tolerance; detecting a color of each egg in the carton to decide whether the colors of the eggs are consistent; measuring a weight of the egg in the carton to determine whether the weight of the egg is within an egg weight tolerance; and measuring a density of the egg to determine whether the egg is within a density tolerance.

Abstract: Systems and methods for dispensing a product from a dispensing kiosk are provided.

Abstract: A method and system for wireless data sharing enables wireless data to be shared efficiently between unfamiliar electronic devices. The method includes broadcasting identification data and supplementary data from a first electronic device using a first wireless technology; receiving on a second electronic device the identification data and supplementary data; initiating on the second electronic device an application associated with the identification data; matching the supplementary data to predetermined data using the application on the second electronic device; initiating, using the application on the second electronic device, a wireless data connection between the first electronic device and the second electronic device based on the match between the supplementary data and the predetermined data; and sharing data between the first electronic device and the second electronic device, using the wireless data connection.

Abstract: Disclosed herein are chemopreventive methods and topical formulations for the prevention and treatment of ultraviolet light-induced skin cancers, pre-cancerous lesions, and hyperproliferative disorders in mammals, such as humans, utilizing doses of non-steroidal anti-inflammatory drugs. Low doses of non-steroidal anti-inflammatory drugs are present in the topical formulations and allow continued regular use over an extended period of time to prevent such disorders. In particular, the present invention is particularly suitable for non-melanoma skin cancers as these cancers tend to appear in areas of the skin that have had excess sun exposure (head, neck and arms) meaning that the chemopreventive agent would not need to be applied over the entire body of the typical patient. Moreover, it is possible to identify “high-risk” individuals within the populations because people who report one episode of NMSC tend to have a high incidence of a subsequent episode.

Abstract: Disclosed herein are chemopreventive methods and topical formulations for the prevention and treatment of ultraviolet light-induced skin cancers, pre-cancerous lesions, and hyperproliferative disorders in mammals, such as humans, utilizing doses of non-steroidal anti-inflammatory drugs. Low doses of non-steroidal anti-inflammatory drugs are present in the topical formulations and allow continued regular use over an extended period of time to prevent such disorders. In particular, the present invention is particularly suitable for non-melanoma skin cancers as these cancers tend to appear in areas of the skin that have had excess sun exposure (head, neck and arms) meaning that the chemopreventive agent would not need to be applied over the entire body of the typical patient. Moreover, it is possible to identify “high-risk” individuals within the populations because people who report one episode of NMSC tend to have a high incidence of a subsequent episode.

Abstract: Disclosed herein are chemopreventive methods and topical formulations for the prevention and treatment of ultraviolet light-induced skin cancers, pre-cancerous lesions, and hyperproliferative disorders in mammals, such as humans, utilizing doses of non-steroidal anti-inflammatory drugs. Low doses of non-steroidal anti-inflammatory drugs are present in the topical formulations and allow continued regular use over an extended period of time to prevent such disorders. In particular, the present invention is particularly suitable for non-melanoma skin cancers as these cancers tend to appear in areas of the skin that have had excess sun exposure (head, neck and arms) meaning that the chemopreventive agent would not need to be applied over the entire body of the typical patient. Moreover, it is possible to identify “high-risk” individuals within the populations because people who report one episode of NMSC tend to have a high incidence of a subsequent episode.